Literature DB >> 22358580

Generation of lymphokine activated killer cells in a new high density dialyzing culture apparatus.

Y Kohgo1, S Sakamaki, Y Kanisawa, S Nojiri, Y Ueno, Y Itoh, M Takahashi, Y Sasagawa, S Hosoi, S Sato, Y Niitsu.   

Abstract

In order to establish an efficient culture system for the generation of lymphokine activated killer (LAK) cells, we have developed a new device which is essentially based on a continuous dialyzing culture vessel. LAK cells grown in such a system showed higher cytotoxicity than those grown under conventional culture conditions. By using this new apparatus with continuous regulation of infused interleukin 2, nutritional medium, and pO(2) and pCO(2), yields of 2×10(7) cells/ml were achieved and maintained for more than 21 days. These cells also showed a significant increase of LAK activity on a per cell basis.

Entities:  

Year:  1989        PMID: 22358580     DOI: 10.1007/BF00365414

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  14 in total

1.  Lysis of human solid tumor cells by lymphokine-activated natural killer cells.

Authors:  K Itoh; A B Tilden; C M Balch
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

2.  Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.

Authors:  S Rosenberg
Journal:  J Natl Cancer Inst       Date:  1985-10       Impact factor: 13.506

3.  Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

Authors:  S A Rosenberg; M T Lotze; L M Muul; S Leitman; A E Chang; S E Ettinghausen; Y L Matory; J M Skibber; E Shiloni; J T Vetto
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

4.  An enzyme-immunoassay for human interleukin-2.

Authors:  N Moriya; K Kato; N Suzuki; T Yamada; O Nishimura
Journal:  J Immunoassay       Date:  1987

5.  Hydroxyl radical scavengers inhibit human natural killer cell activity.

Authors:  M Suthanthiran; S D Solomon; P S Williams; A L Rubin; A Novogrodsky; K H Stenzel
Journal:  Nature       Date:  1984 Jan 19-25       Impact factor: 49.962

6.  Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease.

Authors:  A S Kadish; A T Doyle; E H Steinhauer; N A Ghossein
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

7.  Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells.

Authors:  K Oshimi; Y Oshimi; M Akutsu; Y Takei; H Saito; M Okada; H Mizoguchi
Journal:  Blood       Date:  1986-10       Impact factor: 22.113

8.  Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission.

Authors:  A Adler; P A Chervenick; T L Whiteside; E Lotzová; R B Herberman
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

9.  Functional analysis of cloned germinal center CD4+ cells with natural killer cell-related features. Divergence from typical T helper cells.

Authors:  A Velardi; M C Mingari; L Moretta; C E Grossi
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

10.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  1 in total

1.  A new culture system for the cultivation of mammalian cells for the production of several biologically active substances.

Authors:  M Murata; M Togami; Y Tawara; K Onodera
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.